The Immediate Effects of Tissue Flossing on Knee Flexion Range of Motion
1 other identifier
interventional
58
1 country
1
Brief Summary
The purpose of this study is to verify the immediate effects of Tissue Flossing on knee flexion range of motion
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Feb 2024
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2024
CompletedFirst Posted
Study publicly available on registry
January 12, 2024
CompletedStudy Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2024
CompletedApril 4, 2024
April 1, 2024
26 days
January 3, 2024
April 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change of knee range of motion
Data will be collected in two moments: baseline (M0) and after the intervention/control (M1). The knee flexion range of motion will be measured using a smartphone app "Goniometer Pro". The distance between the lateral femoral epicondyle and the center of the lateral malleolus will be assessed. To measure the knee flexion angle, the participant will be placed in the prone position with the hip and knee extended at 0° (goniometer initial position 0°) with the foot relaxed and the contralateral leg extended. For active range of motion, the participant will be asked to perform maximum knee flexion in the prone position. To measure passive movement, the examiner will perform maximum knee flexion on participants in the same position. The average of three repetitions of ranges of movement will be recorded with 30-second rest intervals.
[Time Frame: Change from Baseline (M0) to Immediately after intervention or control (M1)]
Study Arms (2)
Intervention group
ACTIVE COMPARATORThe floss band will be applied to the knee of the dominant lower limb in the intervention group (IG). While the participant will stand and perform a slight knee flexion, the band will be rolled upwards from the tibial tuberosity to 5 cm above the femoral epicondyle. The patella will not be covered. Pressure will be produced by rolling the joint with 50% tension and 50% overlap. After applying the floss band, passive mobilization will be performed - 20 repetitions of knee flexion and extension and an active movement task - 20 squats. Participants will be instructed to perform knee flexion and extension to their extreme range of motion and to complete the mobility exercises within two minutes. After two minutes, the floss band will be removed and participants will be instructed to stand up and walk for a minute to allow blood to flow back to the foot.
Control group
NO INTERVENTIONFor the CG, after initial assessment, participants without a floss band will perform the same two functional movement tasks (active and passive) with 20 repetitions as the GI for 2 minutes. After two minutes, participants will be instructed to get up and walk for one minute like the intervention group.
Interventions
While the participant will stand and perform a slight knee flexion, the band will be rolled upwards from the tibial tuberosity to 5 cm above the femoral epicondyle. The patella will not be covered. Pressure will be produced by rolling the joint with 50% tension and 50% overlap.
Eligibility Criteria
You may qualify if:
- healthy people between 18 and 35 years old with normal mobility of the joints of the lower limbs of the body.
You may not qualify if:
- deformities in the region of the lower limbs of the body, complaints in this region in the last 6 months, surgical procedures, venous thrombotic disease, heart disease, respiratory disease, or neurological, orthopedic, dermatitis, or neuromuscular problems in the lower quadrant that may disrupt musculoskeletal function. Also high blood pressure, latex allergies, lymphedema and individuals taking anticoagulant medication, and cortisteroid therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Escola Superior Saúde Fernando Pessoa
Porto, 4200-253 Porto, Portugal
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 3, 2024
First Posted
January 12, 2024
Study Start
February 15, 2024
Primary Completion
March 12, 2024
Study Completion
March 29, 2024
Last Updated
April 4, 2024
Record last verified: 2024-04